Filgotinib medication (FOI)
Filgotinib medication (FOI)Produced by the Freedom of Information office
Authored by Government of Jersey and published on 01 December 2021.
Prepared internally, no external costs.
Please can you tell me the total number of patients who have received at least one dose of Filgotinib (Brand name Jyseleca) for rheumatoid arthritis, from the hospital pharmacy system, in the last eight months.
The total number of patients who have received Filgotinib from the hospital pharmacy system in the last eight months was 53 patients.
The hospital pharmacy system does not provide information as to what indication a medication is given for, although rheumatoid arthritis is the licensed indication for Filgotinib.